Boehringer Ingelheim opens $809.2m biopharmaceutical plant in Austria
The new facility will house fermenters that will be capable of handling capacities of 185,000l.
Austria
Latest in
Austria
Sandoz plans $183m boost to antibiotics production in Europe
Sandoz intends to invest $183m (€150m) to boost its European antibiotics manufacturing network.
GSK and CureVac enter Covid-19 vaccine development collaboration
GlaxoSmithKline (GSK) and CureVac have entered a €150m ($180m) collaboration to jointly develop mRNA vaccines for Covid-19.
Sandoz partners with Austria to boost antibiotics production
Swiss pharmaceutical company Novartis unit Sandoz has partnered with the Austrian Government to boost integrated antibiotics production in Europe.
Apeiron Biologics gets regulatory approvals for Phase II Covid-19 trial
Apeiron Biologics has secured approvals from regulatory agencies in Austria, Germany and Denmark to conduct a Phase II clinical trial…
OncoOne launches with €13m Series A funding
Austria-based OncoOne closed its Series A funding round with €13m raised. This financing will be used to officially launch the…
ByDeals this week: GlaxoSmithKline, Incyte, Novo Nordisk
GlaxoSmithKline (GSK) and Pfizer have agreed to combine their consumer healthcare businesses with combined annual sales of £9.8bn ($12.7bn) and…
Sandoz and Ares Genetics partner to develop anti-infectives platform
Novartis division Sandoz has partnered with Ares Genetics to develop a digital anti-infectives platform to support drug development and life…